BUZZ-Australia's Tetratherix soars on Alcon funding

Reuters

Dec 01, 2025

** Shares of Australia's Tetratherix TTX.AX rise as much as 10.1% to A$4.24, their highest level since mid-November

** Stock set for its strongest session in six weeks, if current trends hold

** Regenerative biomaterials maker says BioOptix, which is co's JV partner has entered agreement with Alcon Research

** Under agreement, Alcon Research to provide funding to speed up commercialization of products from Tetramatrix platform technology

** Tetramatrix platform technology is a biomaterial platform which creates implantable products for diverse clinical needs - co's website

** Stock up near 25% since it listed on June 30

(Reporting by Aamir Sheik Khalid in Bengaluru)

((Aamir.SheikKhalid@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2588523717"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2588523717\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2588523717?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-01 10:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2588523717","market":"us","top_or_hot":-1,"title":"BUZZ-Australia's Tetratherix soars on Alcon funding","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Australia's Tetratherix soars on Alcon funding</title></head><body><p>** Shares of Australia's Tetratherix <span>TTX.AX</span> rise as much as 10.1% to A$4.24, their highest level since mid-November</p><p>** Stock set for its strongest session in six weeks, if current trends hold</p><p>** Regenerative biomaterials maker <span>says</span> BioOptix, which is co's JV partner has entered agreement with Alcon Research</p><p>** Under agreement, Alcon Research to provide funding to speed up commercialization of products from Tetramatrix platform technology</p><p>** Tetramatrix platform technology is a biomaterial platform which creates implantable products for diverse clinical needs - co's website</p><p>** Stock up near 25% since it listed on June 30</p><p> (Reporting by Aamir Sheik Khalid in Bengaluru)</p><p> ((Aamir.SheikKhalid@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Australia's Tetratherix soars on Alcon funding</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Australia's Tetratherix soars on Alcon funding\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-01 10:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Australia's Tetratherix soars on Alcon funding</title></head><body><p>** Shares of Australia's Tetratherix <span>TTX.AX</span> rise as much as 10.1% to A$4.24, their highest level since mid-November</p><p>** Stock set for its strongest session in six weeks, if current trends hold</p><p>** Regenerative biomaterials maker <span>says</span> BioOptix, which is co's JV partner has entered agreement with Alcon Research</p><p>** Under agreement, Alcon Research to provide funding to speed up commercialization of products from Tetramatrix platform technology</p><p>** Tetramatrix platform technology is a biomaterial platform which creates implantable products for diverse clinical needs - co's website</p><p>** Stock up near 25% since it listed on June 30</p><p> (Reporting by Aamir Sheik Khalid in Bengaluru)</p><p> ((Aamir.SheikKhalid@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7067","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nL6N3X703I:1","article_id":"2588523717","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2588523717","pubTimestamp":1764556375,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Australia's Tetratherix soars on Alcon funding** Shares of Australia's Tetratherix TTX.AX rise as much as 10.1% to A$4.24, their highest level since mid-November** Stock set for its strongest session in six weeks, if current trends hold** Regenerative biomaterials maker says BioOptix, which is co's JV partner has entered agreement with Alcon Research** Under agreement, Alcon Research to provide funding to speed up commercialization of products from Tetramatrix platform technology** Tetramatrix platform technology is a biomaterial platform which creates implantable products for diverse clinical needs - co's website** Stock up near 25% since it listed on June 30  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7067":"生物科技","TTX.AU":"Tetratherix Ltd"},"translate_title":"BUZZ-澳大利亚Tetratherix因爱尔康融资而飙升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TTX.AU":0.9},"content_text":"BUZZ-Australia's Tetratherix soars on Alcon funding** Shares of Australia's Tetratherix TTX.AX rise as much as 10.1% to A$4.24, their highest level since mid-November** Stock set for its strongest session in six weeks, if current trends hold** Regenerative biomaterials maker says BioOptix, which is co's JV partner has entered agreement with Alcon Research** Under agreement, Alcon Research to provide funding to speed up commercialization of products from Tetramatrix platform technology** Tetramatrix platform technology is a biomaterial platform which creates implantable products for diverse clinical needs - co's website** Stock up near 25% since it listed on June 30 (Reporting by Aamir Sheik Khalid in Bengaluru) ((Aamir.SheikKhalid@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}